This content is from: Premium Why 2019 Wasn’t All Bad for Unicorns While the recent headlines were negative, 2019 was still a pretty good year for fund raising. By Stephen Taub December 30, 2019
This content is from: Premium Healthcare Hedge Funds Shine as This Year’s Winning Strategy Managers are plowing money into oncology and genomics-oriented companies — and reaping rewards. By Michelle Celarier October 08, 2018
This content is from: Premium Biotech IPOs Are a Mixed Bag for Hedge Funds A recent spate of biotech company IPOs has yielded some early winners and losers. By Stephen Taub July 24, 2019
This content is from: Premium Viking’s Hybrid Fund Surges on Private Investments The fund, which invests in a mix of private and public funds, is way outpacing its better-known siblings. By Stephen Taub October 08, 2019
This content is from: Corner Office Izzy Englander’s Big Payday Thanks to gains in Millennium’s flagship funds last year, the money manager makes another appearance on Institutional Investor’s Rich List. By Stephen Taub April 02, 2019
This content is from: Research The Fintech Finance 40: Colin Beirne Partner, Two Sigma Ventures By Jeffrey Kutler January 15, 2018
Sponsored Scaling to Innovative New Heights A quant shop pursues sophisticated and complex new strategies through systemization – and in a cost-efficient way. Sponsored by Systematica Investments July 13, 2020
